Chlorine in PDB 8s9z: Mpro Inhibitors of Sars-Cov-2

Enzymatic activity of Mpro Inhibitors of Sars-Cov-2

All present enzymatic activity of Mpro Inhibitors of Sars-Cov-2:
3.4.22.69;

Protein crystallography data

The structure of Mpro Inhibitors of Sars-Cov-2, PDB code: 8s9z was solved by L.R.Blankenship, W.R.Liu, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 24.46 / 1.60
Space group I 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 54.267, 82.318, 86.441, 90, 96.17, 90
R / Rfree (%) 23.8 / 25.8

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Mpro Inhibitors of Sars-Cov-2 (pdb code 8s9z). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Mpro Inhibitors of Sars-Cov-2, PDB code: 8s9z:

Chlorine binding site 1 out of 1 in 8s9z

Go back to Chlorine Binding Sites List in 8s9z
Chlorine binding site 1 out of 1 in the Mpro Inhibitors of Sars-Cov-2


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Mpro Inhibitors of Sars-Cov-2 within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Cl4

b:50.7
occ:1.00
CL1 B:ZV74 0.0 50.7 1.0
C30 B:ZV74 1.8 26.4 1.0
C29 B:ZV74 2.7 25.1 1.0
SG A:CYS145 2.9 26.0 1.0
O7 B:ZV74 3.1 25.3 1.0
O B:PHE3 3.6 24.5 1.0
N4 B:ZV74 3.7 23.6 1.0
OD1 A:ASN142 3.9 32.6 1.0
C B:PHE3 4.0 25.3 1.0
N A:GLY143 4.0 19.0 1.0
N2 B:ZV74 4.0 22.9 1.0
CA A:GLY143 4.5 21.6 1.0
CB A:CYS145 4.5 19.8 1.0
O B:HOH101 4.5 27.9 1.0
NE2 A:HIS41 4.6 21.8 1.0
CB B:PHE3 4.7 25.6 1.0
CG A:ASN142 4.8 33.4 1.0
C26 B:ZV74 4.9 21.4 1.0

Reference:

L.R.Blankenship, W.R.Liu. Structure of MPI89 with Mpro of Sars-Cov-2 at 1.85A Resolution. To Be Published.
Page generated: Tue Jul 30 12:22:10 2024

Last articles

Zn in 8S6Z
Zn in 8S4F
Zn in 8RR4
Zn in 8RR3
Zn in 8RR1
Zn in 8RIP
Zn in 8RL5
Zn in 8RIO
Zn in 8RL9
Zn in 8RLA
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy